Literature DB >> 22272765

Protein kinase C and oxidative stress in an animal model of mania.

Amanda Valnier Steckert1, Samira Silva Valvassori, Francielle Mina, Jéssica Lopes-Borges, Roger Bitencourt Varela, Flávio Kapczinski, Felipe Dal-Pizzol, João Quevedo.   

Abstract

The present study aims to investigate the effects of protein kinase C using the inhibitor Tamoxifen (TMX) on oxidative stress in a rat animal model of mania induced by d-amphetamine (d-AMPH). In the reversal model, d-AMPH or saline (Sal) were administered to rats for 14 days, and between days 8-14, rats were treated with TMX or Sal. In the prevention model, rats were pretreated with TMX or Sal, and between days 8-14, d-AMPH or Sal were administrated. In both experiments locomotor activity and risk-taking behavior were assessed by open-field test and oxidative stress was measured in prefrontal, amygdala, hippocampus and striatum. The results showed that TMX reversed and prevented d- AMPH-induced behavioral effects. In addition, the d-AMPH administration induced oxidative damage in both structures tested in two models. The TMX was able to reverse and prevent this impairment, however in a way dependent of cerebral area and technique evaluated. These findings reinforce the hypothesis that PKC play an important role in the pathophysiology of BD and the need for the study of inhibitors of PKC as a possible target for treatment the BD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22272765     DOI: 10.2174/156720212799297056

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  9 in total

1.  Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia.

Authors:  S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-24       Impact factor: 5.270

Review 2.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

Review 3.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

Review 4.  Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.

Authors:  Ashwini Saxena; Giselli Scaini; Daniela V Bavaresco; Camila Leite; Samira S Valvassori; André F Carvalho; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2017-10-07

5.  Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study.

Authors:  Ayşegül Yildiz; Burç Aydin; Necati Gökmen; Ayşegül Yurt; Bruce Cohen; Pembe Keskinoglu; Dost Öngür; Perry Renshaw
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-03

6.  Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.

Authors:  Samira S Valvassori; Camila O Arent; Amanda V Steckert; Roger B Varela; Luciano K Jornada; Paula T Tonin; Josiane Budni; Edemilson Mariot; Flávio Kapczinski; João Quevedo
Journal:  Mol Neurobiol       Date:  2014-08-28       Impact factor: 5.590

Review 7.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

8.  Effects of tamoxifen and glutamate and glutamine levels in brain regions in repeated sleep deprivation-induced mania model in mice.

Authors:  Selda Özakman; M Zafer Gören; Asiye Nurten; Nurdan Tekin; Rivaze Kalaycı; Nurhan Enginar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-26       Impact factor: 3.000

9.  Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.

Authors:  Samira S Valvassori; Gustavo C Dal-Pont; Wilson R Resende; Roger B Varela; Bruna R Peterle; Fernanda F Gava; Francielle G Mina; José H Cararo; André F Carvalho; João Quevedo
Journal:  Int J Neuropsychopharmacol       Date:  2017-11-01       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.